Assessing the efficacy of varicocelectomy, antioxidants, FSH treatment, and lifestyle modifications on sperm DNA fragmentation: a systematic review and meta-analysis.

Tamás Kói, Szilárd Váncsa, Péter Hegyi, Anett Szabó, Júlia Ács, Nándor Ács, Tibor Szarvas, Péter Nyirády, Zsolt Kopa, Réka Juhász Hermánné

Journal: Scientific reports 2025;15(1):10118

PMID: 40128318

Abstract

Infertility affects 15% of couples in developed countries, 50% accounting for male origin. In 2021, sperm DNA fragmentation (SDF) testing was incorporated into male fertility evaluations as an evidence-based functional test. We aimed to assess the effect of interventions that could potentially improve SDF. A random-effect meta-analysis was performed with a systematic search in three databases. Pooled mean differences (MD) with 95% confidence intervals (CI) were calculated. Initially, 36,531 articles were found, of which 86 papers with over 8,000 patients were included. Three months following varicocelectomy, the decrease in SDF was -6.74% (CI: -9.40, -4.08) compared to preoperative data of patients, whereas it was -12.39% (CI: -22.41, -2.36) after six months and -10.06% (CI: -22.69, + 2.56) at twelve months. A dose-dependent effect could also be observed in grade II and III varicoceles. The overall SDF decrease at three months was -4.27% (CI: -6.11, -2.43) for antioxidants, -4.51% (CI: -6.81, -2.20) for combined antioxidant therapy and -3.36% (CI: -4.44, -2.28) for monotherapy. In terms of follicle-stimulating hormone treatment (FSH) at three months, the change in SDF was -6.66% (CI: -9.64, -3.69). For lifestyle modifications, a change of -3.24% (CI: -5.33, -1.16) was observed at three months. Other interventions are narratively summarized in the systematic review. Of the interventions reviewed, varicocelectomy is the most effective in reducing SDF at six months, FSH treatment might be useful, antioxidants appear questionable, and lifestyle interventions require more studies of similar designs to draw firm conclusions.

© 2025. The Author(s).

Address: Department of Urology, Semmelweis University, Üllői út 78/b, H-1082, Budapest, Hungary.; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.; Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary.; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Stochastics, Institute of Mathematics, Budapest University of Technology and Economics, Budapest, Hungary.; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Dietetics and Nutrition Sciences, Semmelweis University, Budapest, Hungary.; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary.; Department of Urology, Semmelweis University, Üllői út 78/b, H-1082, Budapest, Hungary.; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Urology, University of Duisburg-Essen and German Cancer Consortium, Essen, Germany.; Department of Urology, Semmelweis University, Üllői út 78/b, H-1082, Budapest, Hungary. [email protected].; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.